#53 Heparin-Induced Thrombocytopenia: 5 Pearls Segment

Published: Nov. 13, 2019, 6 a.m.

Get CME Credit (https://www.acponline.org/cme-moc/online-learning-center/heparin-induced-thrombocytopenia-5-pearls-segment) with ACP!\n\nFull Transcript with references and show notes (https://www.coreimpodcast.com/2019/11/13/5-pearls-on-heparin-induced-thrombocytopenia/)\n\nTime Stamps\n\n4:30 What is the daily risk of thrombosis if HIT Is left untreated?\n5:40 What happens during platelet activation?\n07:11 How long does it take for patients to develop for IgG antibodies to Heparin to form? \n09:52 Is HIT common?\n10:28 Who is at higher risk for HIT?\n11:48 Why does low molecular weight heparin have a lower risk for HIT than unfractionated heparin? \n15:30 Approach to thrombocytopenia\n17:44 How do medications cause thrombocytopenia?\n18:38 With medications, what is the time course between medication initiation and thrombocytopenia?\n22:20 What is the sensitivity and specificity of anti-PF4 antibody?\n23:58 How does the serotonin-release assay (SRA) work?\n29:10 What type of anticoagulant do you choose for treating HIT?\n31:58 Why is it important to not use warfarin in patients with platelet counts\n\nFind the best disability insurance for you: https://www.patternlife.com/disability-insurance?campid=497840\n\nAdvertising Inquiries: https://redcircle.com/brands\n\nPrivacy & Opt-Out: https://redcircle.com/privacy